IRIDEX CORP
IRIX· Nasdaq· Electromedical & Electrotherapeutic Apparatus
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -4.3%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +7.7%
We record prices for the companies we cover; IRIX is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 16.9M
- Revenue
- $52.7M
- Free cash flow
- -$2.3M
- Owner earnings
- -$3.0M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- 36.5%
- Operating
- -4.9%
- Net
- -8.4%
- Free cash flow
- -4.3%
- Owner earnings
- -5.8%
- Stock pay
- 1.5%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -90.1%
- ROE, 5 yr avg
- -136.4%
Growth (CAGR)
- Revenue, 3 yr
- -2.6%
- Revenue, 5 yr
- 7.7%
- Revenue, 9 yr
- 1.5%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 9 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
- Free cash flow, 9 yr
- –
Financial health · FY2025
- Cash and investments
- $6.0M
- Total debt
- $3.7M
- Net cash
- $2.3M
- Debt/Equity
- 0.8x
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 4.1%
Financials: ten years from the 10-Ks
Revenue
$52.7M
+1.5% a year over 9 years
FY2016FY2025
Margins
Gross36.5%Operating-4.9%Net-8.4%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow-$2.3MOwner earnings-$3.0M
FY2025
FY2016FY2025
Diluted shares
16.9M
+66.5% over 9 years, net dilution
FY2016FY2025
Net cash
$2.3M
$2.3M more cash than debt
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $46.2M | $41.6M | $42.6M | $43.4M | $36.3M | $53.9M | $57.0M | $51.9M | $48.7M | $52.7M |
| Revenue growth | 10.5% | -9.9% | 2.4% | 2.0% | -16.3% | 48.3% | 5.7% | -9.0% | -6.2% | 8.2% |
| Gross margin | 45.1% | 37.3% | 41.0% | 41.3% | 42.8% | 42.4% | 44.5% | 42.0% | 40.1% | 36.5% |
| Operating margin | -5.6% | -31.0% | -30.2% | -20.7% | -18.1% | -14.0% | -13.2% | -19.3% | -17.1% | -4.9% |
| Net income | -$11.7M | -$12.9M | -$12.8M | -$8.8M | -$6.3M | -$5.2M | -$7.5M | -$9.6M | -$8.9M | -$4.4M |
| Net margin | -25.4% | -30.9% | -30.1% | -20.3% | -17.4% | -9.7% | -13.2% | -18.5% | -18.3% | -8.4% |
| Diluted EPS | $-1.15 | $-1.11 | $-1.05 | $-0.64 | $-0.46 | $-0.34 | $-0.47 | $-0.59 | $-0.54 | $-0.26 |
| Return on invested capital? | – | – | – | – | – | – | – | – | – | – |
| Cash | ||||||||||
| Operating cash flow | -$144.0K | -$3.6M | -$10.0M | -$7.9M | -$3.2M | $8.2M | -$9.5M | -$6.7M | -$7.3M | -$2.1M |
| Capital expenditure | $1.1M | $575.0K | $440.0K | $128.0K | $97.0K | $213.0K | $286.0K | $109.0K | $13.0K | $143.0K |
| Free cash flow | -$1.2M | -$4.1M | -$10.5M | -$8.0M | -$3.3M | $8.0M | -$9.8M | -$6.9M | -$7.3M | -$2.3M |
| Stock-based compensation | $1.8M | $1.9M | $1.8M | $1.7M | $1.1M | $1.6M | $1.6M | $1.6M | $1.2M | $775.0K |
| Owner earnings? | -$3.0M | -$6.1M | -$12.3M | -$9.7M | -$4.5M | $6.4M | -$11.4M | -$8.5M | -$8.5M | -$3.0M |
| Free cash flow per share | $-0.12 | $-0.36 | $-0.86 | $-0.59 | $-0.24 | $0.52 | $-0.62 | $-0.42 | $-0.44 | $-0.13 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | $59.0K | – | – | – | – | – | – | – | – | – |
| Diluted shares | 10.2M | 11.6M | 12.2M | 13.7M | 13.8M | 15.4M | 15.9M | 16.1M | 16.4M | 16.9M |
| Share count change? | 0.4% | 13.6% | 5.6% | 12.4% | 1.0% | 11.4% | 3.4% | 1.2% | 1.9% | 3.0% |
| Balance sheet | ||||||||||
| Cash and equivalents | $23.7M | $21.7M | $21.2M | $12.7M | $11.6M | $23.9M | $13.9M | $7.0M | $2.4M | $6.0M |
| Short-term investments | – | – | – | – | – | – | – | – | – | – |
| Total debt | – | – | – | – | $1.2M | – | – | $0 | $2.7M | $3.7M |
| Net debt | – | – | – | – | -$10.4M | – | – | -$7.0M | $313.0K | -$2.3M |
| Shareholders' equity | $39.2M | $30.5M | $30.0M | $22.7M | $17.4M | $23.3M | $17.2M | $9.5M | $2.1M | $4.9M |
Latest filings
| 2026-08-18 | 10-Q | Quarterly report |
| 2026-08-18 | 8-K | Earnings release |
| 2026-05-19 | 10-Q | Quarterly report |
| 2026-05-19 | 8-K | Earnings release |
| 2026-04-24 | DEF 14A | Proxy statement |
| 2026-04-02 | 10-K | Annual report |
| 2026-03-26 | 8-K | Earnings release |
| 2026-01-12 | 8-K | Earnings release |
| 2025-11-12 | 10-Q | Quarterly report |
| 2025-11-12 | 8-K | Earnings release |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
